Evofem Biosciences, Inc. (EVFM) EPS Estimated At $-0.31

Analysts expect Evofem Biosciences, Inc. (NASDAQ:EVFM) to report $-0.31 EPS on November, 6.They anticipate $0.40 EPS change or 56.34 % from last quarter’s $-0.71 EPS. After having $-0.35 EPS previously, Evofem Biosciences, Inc.’s analysts see -11.43 % EPS growth. The stock decreased 0.20% or $0.01 during the last trading session, reaching $5.09. About 9,454 shares traded. Evofem Biosciences, Inc. (NASDAQ:EVFM) has risen 117.94% since November 1, 2018 and is uptrending. It has outperformed by 117.94% the S&P500.

Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. The company has market cap of $237.20 million. The company's product includes, Amphora contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections, and antimicrobial drug product to prevent the reoccurrence of bacterial vaginosis. It currently has negative earnings. It also offers AMPOWER clinical research study, Chlamydia/Gonorrhea prevention clinical trial, and reduction in the recurrence of bacterial vaginosis clinical trial.

More notable recent Evofem Biosciences, Inc. (NASDAQ:EVFM) news were published by: Prnewswire.com which released: “Evofem Biosciences to Report Second Quarter 2019 Results and Provide Corporate Update on August 6, 2019 – PRNewswire” on July 30, 2019, also Prnewswire.com with their article: “Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors – PRNewswire” published on June 10, 2019, Seekingalpha.com published: “Akorn and Brookdale Senior Living among healthcare gainers; Catalyst Pharmaceuticals leads the losers – Seeking Alpha” on May 07, 2019. More interesting news about Evofem Biosciences, Inc. (NASDAQ:EVFM) were released by: Finance.Yahoo.com and their article: “Evofem Biosciences to Present at Upcoming Healthcare Conferences – Yahoo Finance” published on August 22, 2019 as well as Streetinsider.com‘s news article titled: “Cantor Fitzgerald Transfers Coverage on Evofem Biosciences Inc (EVFM) at Overweight – StreetInsider.com” with publication date: October 16, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.